Thirty is the age to stand firm andintheprimeoflife | Keyuan Pharma & Linuo Pharma won many honors at the 30th anniversary celebration of Linuo Group!
Thirty is the age to stand firm and in the prime of life, to work hard towards the future! On September 28, Linuo Group ushered in an important milestone in its glorious development history—the 30th anniversary celebration. At this grand celebration, Keyuan Pharma (stock code: 301281.SZ) & Linuo Pharma, an important member of Linuo group's big health industry sector, won "Advanced Collective" and many other awards for outstanding performance and outstanding contributions.
20 years of glory, building the future together
As the second listed company of Linuo Group, Keyuan Pharma & Linuo Pharma has accumulated profound technical R&D strength and innovation capabilities in the 20-year development process, actively integrated into the "Belt and Road" construction, deepened cooperation with many domestic and foreign pharmaceutical companies and scientific research institutions, and steadily moved forward in the process of capitalization and internationalization.
At the celebration, Linuo group grandly held the 2023 Annual Commendation Conference, Keyuan Pharma won the honorary title of "Advanced Collective". Winning the honor of "Advanced Collective" is not only a recognition of past achievements, but also an expectation and encouragement for future development.
Commend the advanced and forge an iron army with a firm original intention
After commending the collectives that made outstanding contributions, Linuo group also selected and commended outstanding individuals who made outstanding achievements, and successively issued awards such as the "30th Anniversary Merit Award", "Excellent Management Award", "Business Support Outstanding Contribution Award", "R&D Star", and "Service Star". A total of 125 people from Keyuan Pharma and Linuo Pharma won various honors, demonstrating the team's strong cohesion and contribution.
Innovation empowers, start a new journey together
The 30-year development of Linuo Group has led the glorious journey of Keyuan Pharma & Linuo Pharma from inception to growth. Keyuan Pharma has always adhered to the spirit of "serving China through industry and pursuing excellence", insisted on technological innovation and quality-oriented, and continuously promoted product and industrial upgrades.
In the future, Keyuan Pharma & Lino Pharma will make efforts in the entire chain of R&D, production, and distribution, take technological R&D as the guide, digital manufacturing as the cornerstone, and cultural marketing as the driving force, constantly seek new growth points and market opportunities, actively fulfill social responsibilities, and contribute wisdom and strength to building a healthy China.
